euro adhoc: november AG / Mergers - Acquisitions - Takeovers / november AG assigns peqlab (E)

--------------------------------------------------------------------------------
Disclosure announcement transmitted by euro adhoc. The issuer is responsible
for the content of this announcement.
--------------------------------------------------------------------------------

23.04.2008

Erlangen, 23rd April 2008. With approval of the Supervisory Board november AG
assigns its 51% share of PELAB Biotechnologie GmbH with immediate effect. The
compensation of EUR 1,500,000.00 will be payable by instalments.

Further inquiry note:
Marcus Weichert
Leitung PR/IR
Telefon: +49(0)9131 75088 868
E-Mail: weichert@november.de

end of announcement euro adhoc
--------------------------------------------------------------------------------

emitter: november AG
Ulrich-Schalk-Str. 3
D-91056 Erlangen
phone: +49(0)9131-75088-0
FAX: +49(0)9131-75088-99
mail: info@november.de
WWW: http://www.november.de
sector: Biotechnology
ISIN: DE000A0S9N72
indexes: CDAX, Prime All Share, Technologie All Share
stockmarkets: regulated dealing/prime standard: Börse Frankfurt, free trade:
Börse Berlin, Börse Stuttgart, Börse Düsseldorf, Börse Hannover,
Börse München
language: English

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS - WWW.OTS.AT | OTB

print